Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian Carcinoma
Authors:
- Francesmary ModugnoFMFrancesmary Modugno
- Joel L WeissfeldJWJoel L Weissfeld
- Sarah L BergaSBSarah L Berga
- Roberta B NessRNRoberta B Ness
- 1 August 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 86 (2) , 118-123
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case-control studyObstetrics & Gynecology, 1997
- Estrogen Replacement Therapy and Risk of Epithelial Ovarian CancerGynecologic Oncology, 1996
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Menopause and hormone replacement therapy: An overviewObstetrics & Gynecology, 1996
- The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly WomenNew England Journal of Medicine, 1993
- Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancerInternational Journal of Cancer, 1993
- Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 US Case -Control StudiesAmerican Journal of Epidemiology, 1992
- Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosisBJOG: An International Journal of Obstetrics & Gynaecology, 1992
- NONCONTRACEPTIVE ESTROGEN USE AND EPITHELIAL OVARIAN CANCERAmerican Journal of Epidemiology, 1989
- Risk factors for ovarian cancer: a case-control studyBritish Journal of Cancer, 1989